Inhibition of radiation-induced DNA-protein cross-link repair by glutathione depletion with L-buthionine sulfoximine. 1988

N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
Department of Radiology, Case Western Reserve University School of Medicine, Cleveland, OH 44106-2699.

Cells depleted of their glutathione (GSH) by treatment with L-buthionine sulfoximine (BSO) are more sensitive to ionizing radiation and chemotherapeutic agents. To assess the effects of GSH depletion on repair of radiation-induced DNA damage, we have determined DNA-protein cross-links (DPC) in A549 cells by a nitrocellulose filter binding assay. Untreated A549 cells have a low level of DPC (0.7%), whereas cells incubated with BSO for 92 hours have an elevated level of DPC (1.5%). The dose response for production of radiation-induced DPC is approximately 0.4% DNA bound per 10 Gy for both BSO-treated and non-pretreated cells. Cells not exposed to BSO repair 85% of the radiation-induced DPC in 4 hours. Less repair (55%) is observed for BSO-treated cells incubated for 4 hours postirradiation in conditioned medium, and DPC repair is nearly completely blocked if GSH-depleted cells are given fresh medium during the 4-hour repair interval. The DPC repair is not influenced by the pH of the media between 6.6 and 7.4. Data indicate that intracellular GSH regulates the level of a sulfhydryl-containing repair enzyme, and that other, as yet undefined, nutrients may further influence the steady-state level of DPC.

UI MeSH Term Description Entries
D008717 Methionine Sulfoximine Sulfoximine, Methionine
D004260 DNA Repair The removal of DNA LESIONS and/or restoration of intact DNA strands without BASE PAIR MISMATCHES, intrastrand or interstrand crosslinks, or discontinuities in the DNA sugar-phosphate backbones. DNA Damage Response
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019328 Buthionine Sulfoximine A synthetic amino acid that depletes glutathione by irreversibly inhibiting gamma-glutamylcysteine synthetase. Inhibition of this enzyme is a critical step in glutathione biosynthesis. It has been shown to inhibit the proliferative response in human T-lymphocytes and inhibit macrophage activation. (J Biol Chem 1995;270(33):1945-7) Sulfoximine, Buthionine

Related Publications

N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
May 1993, Cancer research,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
February 2006, Carcinogenesis,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
May 1988, Journal of neurochemistry,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
January 1992, The American journal of physiology,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
June 2012, American journal of hypertension,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
July 1987, British journal of cancer,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
July 1991, Cell biology and toxicology,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
August 1986, Science (New York, N.Y.),
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
January 1996, Parasitology research,
N L Oleinick, and L Y Xue, and L R Friedman, and L L Donahue, and J E Biaglow
September 1995, Research communications in molecular pathology and pharmacology,
Copied contents to your clipboard!